{
    "2021-09-30": [
        [
            {
                "time": "",
                "original_text": "行业动态|医美再生材料大风起 业内研发人士：当前仍是透明质酸钠天下",
                "features": {
                    "keywords": [
                        "医美",
                        "再生材料",
                        "透明质酸钠"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "21深度丨200亿元中成药跨省联盟集采“官宣”，或将淘汰一半参与企业，20多家上市公司态度如何？",
                "features": {
                    "keywords": [
                        "中成药",
                        "集采",
                        "上市公司"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华东医药“母子对簿公堂”新进展：华东宁波拟年底法定清算 诉讼纠纷",
                "features": {
                    "keywords": [
                        "华东医药",
                        "华东宁波",
                        "清算",
                        "诉讼"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华东医药对华东宁波管理未失去控制 将妥善做好后续清算工作",
                "features": {
                    "keywords": [
                        "华东医药",
                        "华东宁波",
                        "清算",
                        "管理"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药回应子公司诉讼事件：计划年底清算华东宁波 坚持高端医美全球化战略布局 诉讼纠纷",
                "features": {
                    "keywords": [
                        "华东医药",
                        "华东宁波",
                        "诉讼",
                        "医美",
                        "全球化战略"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股异动 | 华东医药(000963.SZ)涨9% 子公司英国Sinclair与KioMed签署独家许可协议",
                "features": {
                    "keywords": [
                        "华东医药",
                        "Sinclair",
                        "KioMed",
                        "独家许可协议"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "国际合作"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}